BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28667577)

  • 1. The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.
    Denis JA; Guillerm E; Coulet F; Larsen AK; Lacorte JM
    Mol Diagn Ther; 2017 Dec; 21(6):587-600. PubMed ID: 28667577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing.
    Ståhlberg A; Krzyzanowski PM; Jackson JB; Egyud M; Stein L; Godfrey TE
    Nucleic Acids Res; 2016 Jun; 44(11):e105. PubMed ID: 27060140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-In-One OsciDrop Digital PCR System for Automated and Highly Multiplexed Molecular Diagnostics.
    Li C; Kang N; Ye S; Huang W; Wang X; Wang C; Li Y; Liu YF; Lan Y; Ma L; Zhao Y; Han Y; Fu J; Shen D; Dong L; Du W
    Adv Sci (Weinh); 2024 Jun; 11(21):e2309557. PubMed ID: 38516754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Digital PCR as a Highly Sensitive Diagnostic Tool: A Review].
    Kopylova KV; Kasparov EW; Marchenko IV; Smolnikova MV
    Mol Biol (Mosk); 2023; 57(5):771-781. PubMed ID: 37752642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR inhibition in qPCR, dPCR and MPS-mechanisms and solutions.
    Sidstedt M; Rådström P; Hedman J
    Anal Bioanal Chem; 2020 Apr; 412(9):2009-2023. PubMed ID: 32052066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Methods: Clinical Utilization and Designing a Test Menu.
    Ewalt MD; Hsiao SJ
    Clin Lab Med; 2024 Jun; 44(2):123-135. PubMed ID: 38821636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring DNA quality by digital PCR using probability calculations.
    Gleerup D; Chen Y; Van Snippenberg W; Valcke C; Thas O; Trypsteen W; De Spiegelaere W
    Anal Chim Acta; 2023 Oct; 1279():341822. PubMed ID: 37827643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies.
    Ladas I; Fitarelli-Kiehl M; Song C; Adalsteinsson VA; Parsons HA; Lin NU; Wagle N; Makrigiorgos GM
    Clin Chem; 2017 Oct; 63(10):1605-1613. PubMed ID: 28679646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
    Ashida A; Sakaizawa K; Uhara H; Okuyama R
    Acta Derm Venereol; 2017 Nov; 97(10):1212-1218. PubMed ID: 28681063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Application of Multiplex PCR Seq for the Detection of Somatic Mutations Associated with Myeloid Malignancies.
    Park N; Vassiliou G
    Methods Mol Biol; 2017; 1633():87-99. PubMed ID: 28735482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients.
    Alba-Bernal A; Godoy-Ortiz A; Domínguez-Recio ME; López-López E; Quirós-Ortega ME; Sánchez-Martín V; Roldán-Díaz MD; Jiménez-Rodríguez B; Peralta-Linero J; Bellagarza-García E; Troyano-Ramos L; Garrido-Ruiz G; Hierro-Martín MI; Vicioso L; González-Ortiz Á; Linares-Valencia N; Velasco-Suelto J; Carbajosa G; Garrido-Aranda A; Lavado-Valenzuela R; Álvarez M; Pascual J; Comino-Méndez I; Alba E
    NPJ Breast Cancer; 2024 May; 10(1):36. PubMed ID: 38750090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients.
    Galant N; Nicoś M; Kuźnar-Kamińska B; Krawczyk P
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital PCR for Single-Cell Analysis.
    Fang W; Liu X; Maiga M; Cao W; Mu Y; Yan Q; Zhu Q
    Biosensors (Basel); 2024 Jan; 14(2):. PubMed ID: 38391982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.
    Biglari N; Soltani-Zangbar MS; Mohammadian J; Mehdizadeh A; Abbasi K
    EXCLI J; 2023; 22():752-780. PubMed ID: 37720239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease in solid tumors: an overview.
    Ma Y; Gan J; Bai Y; Cao D; Jiao Y
    Front Med; 2023 Aug; 17(4):649-674. PubMed ID: 37707677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer.
    Vlataki K; Antonouli S; Kalyvioti C; Lampri E; Kamina S; Mauri D; Harissis HV; Magklara A
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclease Enrichment and qPCR Detection of Rare Nucleotide Variants.
    Keraite I; Alvarez-Garcia V; Leslie NR
    Methods Mol Biol; 2023; 2621():41-56. PubMed ID: 37041439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer.
    Bożyk A; Nicoś M
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Promise of Circulating Tumor DNA in Head and Neck Cancer.
    Aulakh SS; Silverman DA; Young K; Dennis SK; Birkeland AC
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.